Osteopathic Manipulative Techniques in Collegiate Dancers

February 27, 2025 updated by: Edward Via Virginia College of Osteopathic Medicine
The goal of this study is to determine how these techniques affect pain levels, movement quality, and balance. Osteopathic Manipulative Techniques, or OMT, is a type of treatment used to treat problems in the bones, muscles, tissues, and joints. The investigators would like to ask the participants to fill out a few questionnaires about their personal history, dance background, pain levels, and movement quality. All participant responses will be completely anonymous, and participants are allowed to refuse to answer any part of the survey. The investigators would also ask participants to complete a balance assessment, which will involve standing on a force plate with their eyes open and closed for 30 seconds each. The initial survey and questionnaires, balance assessment, OMT, and post-practice survey are expected to take about 60 minutes. Each additional survey given after 24-hours and one week will take about 20 minutes each. The follow-up balance test after one week is expected to take less than 5 minutes. Participation in this study would be immensely valuable for us to learn more about the benefits of treating dancers with osteopathic manipulative medicine.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Many dancers base their identities and self-worth on being able to train, rehearse, and perform. Because of this, dancers are more likely to ignore any pain or discomfort and continue dancing, despite the risk of worsening pain or injuries. Injuries are very common in dancers due to repetitive motions, overuse of muscles and joints, improper technique, acute injuries, or energy balance deficits. The most common areas of pain and injury seen in dancers include the hips, knees, ankles, feet, and lumbar spine. While many current treatments are available for dance-related pain and injuries, many of them involve rest and time off from dancing, which many dancers are not willing to do. Although Osteopathic Manipulative Treatment (OMT) is not a substitute for rehabilitation and other treatments necessary for injuries, it may enhance their recovery time and prevent future injuries. This study aims to examine the significance of utilizing OMT to decrease dancers' performance-related pain, increase dancers' movement quality, and increase dancers' balance. OMT is the manipulation of the musculoskeletal system to assist the body in healing and strengthening itself while encouraging resistance to future stressors. Athletes, such as dancers, may find OMT beneficial for decreasing their pain, improving their range of motion, and preventing future injuries. Other athletes have reported satisfaction with OMT modalities in decreasing their injury-related pain and stress, decreasing their need for pain medications, and enhancing their recovery and return to activity. The purpose of this pilot study is to assess dancers' perceived performance-related pain, movement quality, and balance before and after OMT in the regions of the lumbar spine, hips, knees, ankles, and/or feet. Additionally, this study will collect data on the dancers' self-identity in relation to their role as athletes and potential risk factors for disordered eating. Future goals include conducting a larger study to treat and prevent dance-related injuries. Dancers from the University of Louisiana Monroe (ULM) dance team will be recruited to participate in this study. All dancers who choose to participate will be in the experimental group, there will not be a control group. Dancers will complete a survey and questionnaires to provide demographic information, their medical history, dance background, attitudes towards eating, ways in which they identify as an athlete, performance-related pain levels, and perceived movement quality and function while dancing. Dancers will also complete two 30-second balance tests with their eyes open and closed. Following completion of these forms and tests, dancers will be screened for somatic dysfunction(s) and treated appropriately by a medical student from the Edward Via College of Osteopathic Medicine - Louisiana (VCOM) and a supervising physician. After treatment, dancers will attend their practice as normal. Following this, study participants will be re-evaluated immediately after the dance practice, 24 hours later, and one week later. The results of this study may be utilized to write a paper, create a poster presentation, and support a larger study in the future. Significant results would be beneficial in the field of sports medicine to help guide appropriate treatment in dancers and provide more treatment options to allow them to continue dancing.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
15

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Louisiana
      • Monroe, Louisiana, United States, 71203
        • Edward Via College of Osteopathic Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Members of the ULM dance team (HawkLine)

Exclusion Criteria:

  • Non-competitive members of the team, those injured and those that opt out of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Treatment Population
This pilot study will collect data from, diagnose, treat, and reassess dancers on the ULM dance team. They will be asked to complete multiple questionnaires and a survey to determine their medical history, dance background, and mental health. The Multidimensional Pain Questionnaire in Professional Dance (MPQDA) will be used to collect dancer demographics, history, and performance-related pain levels. The Dance Functional Outcome Survey (DFOS) will collect data on the dancers' areas of pain and perceived movement quality and function while performing. Then, the dancer will be treated for 15 minutes using OMT by the osteopathic medical student and supervising physician beginning with the area of greatest restriction within the lower body, including the lumbar spine, hips, knees, ankles, and feet. Following diagnosis and treatment, dancers will attend a dance practice, and be re-evaluated immediately afterward. After 24 hours, dancers will be evaluated again with the force plate.
Procedure: Osteopathic Manipulative Treatment (OMT)
Dancers will then individually be screened for somatic dysfunctions (SD) by a physician and VCOM OMS-III student doctor under their direct supervision. OMS-III student investigators will receive training and be assessed on their abilities before performing OMT on subjects. This will take place at the dancers' place of practice in a private area equipped with an OMM table. The areas to be screened include the lumbar spine, hips, knees, ankles, and feet. All diagnoses in these areas will be documented with specific notation for the area of greatest restriction on paper. After making a diagnosis or multiple diagnoses, the dancer will be treated utilizing OMT for 15 minutes starting with the area of greatest restriction in the lower body by the OMS-III student doctor under direct supervision of a physician, should an adverse event take place. The type of treatment(s) used will be at the discretion of the supervising physician and the VCOM student doctor. They may use any OMT technique, exc

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Changes in perceived pain after Osteopathic Manipulative Treatment (OMT)
Time Frame: 7 days
The Multidimensional Pain Questionnaire in Professional Dance (MPQDA) will be used to collect dancer demographics, history, and performance-related pain levels. The questionnaire includes the following blocks (questions contents are in parentheses):prevalence and localizations; subjective sensation of pain; temporal course of pain. On a four-point ordinal scale from 'not' (= 0) to 'very' (= 3), accompanying symptoms (tension, redness, swelling, warming, restrictions of mobility and resilience) are asked.
7 days
Changes in balance after Osteopathic Manipulative Treatment (OMT)
Time Frame: 7 days
This pilot study will utilize the IsoBALANCE® force plate and scoring system to balance in collegiate dancers before and after receiving OMT. Distance in CM traveled along X and Y axis will be measured during 2 30-second bouts: the first with eyes open and the second with eyes closed. A radius of movement from center (in cm) will also be calculated.
7 days
Changes in performance after Osteopathic Manipulative Treatment (OMT)
Time Frame: 7 days
The Dance Functional Outcome Survey (DFOS) will collect data on the dancers' areas of perceived movement quality and function while performing. 14 questions in the areas of ADL and dance/technique specific "requiring answers of agreement or disagreement to a statement" Max of 40 points; 1 general dance performance grade question (0-100 scale); and Technique section: Max 50 points. Higher score reflects higher function.
7 days
Changes in performance after Osteopathic Manipulative Treatment (OMT)
Time Frame: 7 days
Screening 6 from Athlete's Form #2 on the International Olympic Committee Sport Mental Health Assessment Tool 1 (SMHAT-1) will be used to screen for eating habits and attitudes toward food, eating, weight, and body image that may identify risk factors of disordered eating. The 9-item screen asks about food attitudes over the previous 14 day period. It is scored on a 3 to Zero scale (3=always, 0=sometimes/rarely/never) with higher scores indicating more risk for disordered eating. Topics included guilt after eating; desire to be thinner; satisfaction with body shape; trying to lose weight; avoidance of disappointing parents.
7 days
Changes in performance after Osteopathic Manipulative Treatment (OMT)
Time Frame: 7 days
The Athletic Identity Measurement Scale (AIMS) measures the degree to which an individual identifies with the athlete role. The AIMS is a 10-item self-report questionnaire that was developed to assess domain-specific self-identification as an athlete. The original 10-item AIMS version produced a more has been used in investigations of a wide variety of sport-related phenomena from its 3 sub-scales: social identity, exclusivity, and negative affectivity. For this study, the participants will complete the 10-item version. 8 of the items are worded positively; 2 are worded negatively (inversely scored) using a 1 to 7 Likert scale (Strongly disagree to Strongly agree).
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Edward Via Virginia College of Osteopathic Medicine

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
University of Louisiana Monroe

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Stephanie N Aldret, DO, CAQSM, FAOASM, Edward Via College of Osteopathic Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 1, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 22, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 22, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 24, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 27, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 25, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 27, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2024-181

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

To protect the anonymity of the study subjects.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings